Loading...
Pain Care Labs, the industry leader in non-invasive pain relief devices, announced today that it will introduce its PRO platforms at Arab Health 2022 in Dubai. The PRO devices are an extension of the Company’s proprietary mechanical stimulation (M-Stim®) technology.
“During COVID, availability of home pain management and tele-physical therapy became more urgent,” explains Amy Baxter, MD, CEO, and Chief Medical Officer of Pain Care Labs. “Our personal VibraCool devices were a top pain device for 2021. VibraCool PRO Healthcare allows clinicians to experience thermal M-Stim technology. It’s a game changer for tele-physical therapy. Clinicians accustomed to using electrical stimulation (E-Stim) in the office find M-stim more effective, while also simple, safe, and comfortable enough for patients to use at home.”
At Arab Health 2022, the Company is thrilled to be exhibiting its PRO options for infusion therapies and rehabilitation programs. Additionally, the Company’s DuoTherm will be introduced to the MENA region. If attending Arab Health 2022, please visit Pain Care Labs at H1.G50D.
Pain Care Labs (a dba of MMJ Labs) was established in 2006 by pediatric emergency physician and pain researcher Amy Baxter. Her NIH funding led to the discovery of widespread needle fear, the critical components of pain, and an entire new platform for natural effective pain relief. Now she and her amazing team are out to change the world and eliminate unnecessary pain. The frequency Dr. Baxter used to create Buzzy® is now proven to inhibit pain better than TENS, improve muscle soreness, blood flow, recovery and more. With multiple patents and FDA 510(k) clearances to control and treat pain, the company created the VibraCool®. VibraCool’s M-Stim® pain relief was 2-3.4 times superior to electrical stimulation (TENS) for physical therapy; another demonstrated 35% fewer opioid tablets after knee surgery.